APA (7th ed.) Citation

Bateman, M., Wolf, A., Chimukangara, B., Brust, J. C. M., Lessells, R., Amico, R., . . . O'Donnell, M. R. (2022). Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis. Clinical infectious diseases, 75(9), 1489. https://doi.org/10.1093/cid/ciac232

Chicago Style (17th ed.) Citation

Bateman, Mark, et al. "Adherence Measured Using Electronic Dose Monitoring Is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis." Clinical Infectious Diseases 75, no. 9 (2022): 1489. https://doi.org/10.1093/cid/ciac232.

MLA (9th ed.) Citation

Bateman, Mark, et al. "Adherence Measured Using Electronic Dose Monitoring Is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis." Clinical Infectious Diseases, vol. 75, no. 9, 2022, p. 1489, https://doi.org/10.1093/cid/ciac232.